Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Opus Genetics (IRD) Return on Invested Capital (2022 - 2024)

Opus Genetics has reported Return on Invested Capital over the past 3 years, most recently at 0.01% for Q3 2024.

  • Quarterly Return on Invested Capital fell 1.0% to 0.01% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 0.01% through Sep 2024, down 1.0% year-over-year, with the annual reading at 0.0% for FY2023, 1.0% down from the prior year.
  • Return on Invested Capital was 0.01% for Q3 2024 at Opus Genetics, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.01% in Q3 2023 and troughed at 0.01% in Q3 2024.
  • The 3-year median for Return on Invested Capital is 0.0% (2023), against an average of 0.0%.
  • The largest YoY upside for Return on Invested Capital was -1bps in 2023 against a maximum downside of -1bps in 2023.
  • A 3-year view of Return on Invested Capital shows it stood at 0.01% in 2022, then crashed by -134bps to 0.0% in 2023, then tumbled by -273bps to 0.01% in 2024.
  • Per Business Quant, the three most recent readings for IRD's Return on Invested Capital are 0.01% (Q3 2024), 0.0% (Q2 2024), and 0.0% (Q1 2024).